Other Respiratory System O.R. Procedures with CC DRG Reimbursement

DRG 167 encompasses other respiratory system operating room procedures accompanied by a Complication or Comorbidity and reflects moderate clinical complexity for thoracic surgical care. It matters for inpatient reimbursement because it determines grouping and payment under the Diagnosis-Related Group system, aligning expected resource use with Medicare payment rates.

DRG 167 Overview

DRG 167 covers inpatient cases involving other respiratory system operations performed in the operating room with an associated Complication or Comorbidity. Typical procedures include less common thoracic surgical interventions that do not meet Major Complication or Comorbidity criteria but do involve significant perioperative respiratory management. This Diagnosis-Related Group is important for Medicare payment because it groups clinical complexity and resource use for reimbursement under the Inpatient Prospective Payment System. Accurate assignment affects hospital Medicare payment and billing compliance.

Acute intraoperative and perioperative airway management trials: studies focusing on novel surgical techniques, anesthetic protocols, or perioperative ventilation strategies for patients undergoing non-routine respiratory system operations (for example complex tracheal repairs, thoracic airway reconstructions, or operative management of massive hemoptysis). These trials enroll hospitalized adults who require operating-room respiratory procedures with comorbid complications (e.g., COPD, heart failure) to evaluate intraoperative hemodynamic and respiratory outcomes and immediate complication rates. Results inform surgeons, anesthesiologists, and hospital payers about resource needs, procedure-related risk stratification, and direct costs associated with higher-acuity OR respiratory procedures in this DRG.
Comparative effectiveness studies of surgical versus bronchoscopic or hybrid interventions: head-to-head trials or large prospective registries comparing outcomes, readmissions, and complication profiles of open or thoracoscopic respiratory operations versus endoscopic/bronchoscopic approaches for conditions such as complex airway stenosis, endobronchial lesions, or refractory pulmonary infections. These studies target the subset of patients whose condition can be managed by multiple procedural modalities and examine short-term morbidity, length of stay, need for intensive care, and mid-term functional respiratory outcomes. Findings help clinicians and payers determine which procedural pathway yields better safety and value for patients classified under this DRG, guiding care pathway design and reimbursement policy.
Post-discharge outcomes and care-transition research: observational cohort studies and intervention trials assessing post-discharge complications, pulmonary rehabilitation uptake, and 30–90 day readmission drivers among patients who had other respiratory OR procedures with complicating conditions (CC). These studies include diverse inpatient populations with comorbidities that increase readmission risk and examine discharge planning strategies, home oxygen or ventilator needs, and outpatient surveillance to reduce adverse events after hospital release. Evidence from this area is crucial for hospitals and payers to design discharge protocols, target transitional care resources, and predict downstream utilization costs associated with this DRG.

Acute intraoperative and perioperative airway management trials: studies focusing on novel surgical techniques, anesthetic protocols, or perioperative ventilation strategies for patients undergoing non-routine respiratory system operations (for example complex tracheal repairs, thoracic airway reconstructions, or operative management of massive hemoptysis). These trials enroll hospitalized adults who require operating-room respiratory procedures with comorbid complications (e.g., COPD, heart failure) to evaluate intraoperative hemodynamic and respiratory outcomes and immediate complication rates. Results inform surgeons, anesthesiologists, and hospital payers about resource needs, procedure-related risk stratification, and direct costs associated with higher-acuity OR respiratory procedures in this DRG.
Comparative effectiveness studies of surgical versus bronchoscopic or hybrid interventions: head-to-head trials or large prospective registries comparing outcomes, readmissions, and complication profiles of open or thoracoscopic respiratory operations versus endoscopic/bronchoscopic approaches for conditions such as complex airway stenosis, endobronchial lesions, or refractory pulmonary infections. These studies target the subset of patients whose condition can be managed by multiple procedural modalities and examine short-term morbidity, length of stay, need for intensive care, and mid-term functional respiratory outcomes. Findings help clinicians and payers determine which procedural pathway yields better safety and value for patients classified under this DRG, guiding care pathway design and reimbursement policy.
Post-discharge outcomes and care-transition research: observational cohort studies and intervention trials assessing post-discharge complications, pulmonary rehabilitation uptake, and 30–90 day readmission drivers among patients who had other respiratory OR procedures with complicating conditions (CC). These studies include diverse inpatient populations with comorbidities that increase readmission risk and examine discharge planning strategies, home oxygen or ventilator needs, and outpatient surveillance to reduce adverse events after hospital release. Evidence from this area is crucial for hospitals and payers to design discharge protocols, target transitional care resources, and predict downstream utilization costs associated with this DRG.

OpenPayer

Summary & Overview

Other Respiratory System O.R. Procedures with CC: Inpatient Reimbursement Overview

DRG 167 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes